{
  "id": 3086,
  "url": "https://nnemf.org/research/3086-effect-of-puerarin-on-matrix-metalloproteinase-2-in",
  "title": "Effect of puerarin on matrix metalloproteinase-2 in human fetal scleral fibroblasts treated with low frequency electromagnetic fields.",
  "authors": [
    "Huang Zhu",
    "Xiaojing Cai",
    "Xianqun Fan"
  ],
  "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
  "year": "2013",
  "doi": "10.1016/s0254-6272(14)60039-x",
  "pmid": "24660593",
  "abstract": "OBJECTIVE: To study the effect of puerarin on matrix metalloproteinase-2 (MMP-2) gene and protein expression in human fetal scleral fibroblasts (HFSFs) exposed to extremely low frequency electromagnetic fields (ELF-EMF). METHODS: Cultured HFSFs were exposed to 0.2 mT ELF-EMF for 24 h. The experimental groups were divided into subgroups treated with 0, 0.1, 1 and 10 microM puerarin respectively. The expression of MMP-2 mRNA and protein were detected with real-time polymerase chain reaction and western-blot analysis respectively. RESULTS: MMP-2 mRNA and protein expression increased by 0.793 and 1.130 folds respectively under the exposure of ELF-EMFs at 0.2 mT flux density for 24 h. Puerarin at the concentration of 0.1 microM reversed this effect by 8.53% in mRNA and by 17.97% in protein expression (P < 0.05). The effect was more prominent at higher concentrations (1 and 10 microM, P < 0.01). CONCLUSION: Exposure to ELF-EMFs increased the expression of MMP-2 mRNA and protein in HFSF cells. Puerarin reversed the action to some extent in a specific concentration range. Our results implied that the puerarin might protect scleral tissue from increased expression induced by exposure to ELF-EMFs.",
  "effect": "harm",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "harm",
    "evidenceLabel": "Low",
    "population": "Human fetal scleral fibroblasts (HFSFs) in culture",
    "sampleSize": "—",
    "exposure": "ELF · 24 h",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "Cultured HFSFs exposed to 0.2 mT ELF-EMF for 24 h showed increased MMP-2 mRNA (0.793-fold) and protein (1.130-fold) expression. Puerarin treatment (0.1–10 microM) reversed the ELF-EMF-associated increases, with greater reversal at higher concentrations (reported as statistically significant).",
    "outcomes": [
      "MMP-2 mRNA expression",
      "MMP-2 protein expression"
    ],
    "limitations": [
      "In vitro cell culture model",
      "findings may not translate to humans or tissues in vivo",
      "Frequency of the ELF-EMF exposure not reported in the abstract",
      "Sample size and replication details not reported in the abstract",
      "Only one field intensity (0.2 mT) and one exposure duration (24 h) reported"
    ],
    "keywords": [
      "extremely low frequency electromagnetic fields",
      "ELF-EMF",
      "0.2 mT",
      "human fetal scleral fibroblasts",
      "HFSFs",
      "matrix metalloproteinase-2",
      "MMP-2",
      "puerarin",
      "gene expression",
      "protein expression",
      "RT-PCR",
      "western blot"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"24 h\"\n  },\n  \"population\": \"Human fetal scleral fibroblasts (HFSFs) in culture\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"MMP-2 mRNA expression\",\n    \"MMP-2 protein expression\"\n  ],\n  \"main_findings\": \"Cultured HFSFs exposed to 0.2 mT ELF-EMF for 24 h showed increased MMP-2 mRNA (0.793-fold) and protein (1.130-fold) expression. Puerarin treatment (0.1–10 microM) reversed the ELF-EMF-associated increases, with greater reversal at higher concentrations (reported as statistically significant).\",\n  \"effect_direction\": \"harm\",\n  \"limitations\": [\n    \"In vitro cell culture model; findings may not translate to humans or tissues in vivo\",\n    \"Frequency of the ELF-EMF exposure not reported in the abstract\",\n    \"Sample size and replication details not reported in the abstract\",\n    \"Only one field intensity (0.2 mT) and one exposure duration (24 h) reported\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"extremely low frequency electromagnetic fields\",\n    \"ELF-EMF\",\n    \"0.2 mT\",\n    \"human fetal scleral fibroblasts\",\n    \"HFSFs\",\n    \"matrix metalloproteinase-2\",\n    \"MMP-2\",\n    \"puerarin\",\n    \"gene expression\",\n    \"protein expression\",\n    \"RT-PCR\",\n    \"western blot\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/24660593/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3086",
  "updated": "2026-02-13 07:06:12"
}